What happened
Shares of hotel brand Wyndham Worldwide Corporation (NYSE:WYN) jumped as much as 11.1% in trading Wednesday after reporting first-quarter 2017 earnings. At 3:45 p.m. EDT on Wall Street, shares were still up an impressive 9.6% on the day.
So what
Revenue for the quarter rose just 1% to $1.32 billion, but net income rose 47% from a year ago to $141 million, or $1.33 per share. Adjusted for one-time items, earnings were $1.14 per share, beating Wall Street’s estimate by three cents.
Image source: Getty Images.
Management also said it still expects full-year revenue of $5.80 billion to $5.95 billion and adjusted earnings of $5.98 to $6.18 per share, based on 105.5 million shares outstanding.
Now what
First-quarter results don’t show tremendous growth, but margins are improving slightly, and that’s what had investors pushing shares higher. Keep in mind that growth is still in the low single-digits, and it isn’t expected to pick up significantly soon. With shares trading at 18 times trailing earnings, shares are pretty expensive for a slow-growth stock. For that reason, I’ll sit out today’s pop, but look for opportunities if shares dip to get in at a better value for this hotel industry leader.
best stocks to own: Territorial Bancorp Inc.(TBNK)
Advisors’ Opinion:
- [By Lisa Levin]
Territorial Bancorp (NASDAQ: TBNK) shares touched a new 52-week low of $21.31. Territorial Bancorp shares have dropped 9.43% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.
best stocks to own: Syndax Pharmaceuticals, Inc. (SNDX)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.
- [By Chris Lange]
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).
best stocks to own: PetSmart Inc(PETM)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows Blue Buffalo Pet Products now roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) is well below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been the best performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:
- [By Peter Graham]
A long term performance chart shows Blue Buffalo Pet Products roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) isstill below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been much stronger performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:
best stocks to own: Fortune Brands Home & Security, Inc.(FBHS)
Advisors’ Opinion:
- [By Lisa Levin]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday’s regular session.
best stocks to own: Taranis Resources Inc. (TNREF)
Advisors’ Opinion:
- [By Sara Cornell]
While this can mean excess volatility on the world markets, a silver lining (pun intended) is that mining companies are growing in market favor. Taranis Resources Inc. (OTCBB: TNREF) (TSE: TRO.V), a mining and mineral exploration company based in Colorado and Vancouver, BC, is well positioned for growth in the current volatile markets, largely due to its Thor Deposit, an advanced-stage gold-silver-lead-zinc-copper mineral deposit that has near-surface mineralization that can be extracted with a low cost, open pit mine. Recent discoveries in The Thor Deposit, which is 100% owned by Taranis (OTCBB: TNREF) (TSE: TRO.V), indicate that the area could be prime for development into a significantly bigger mine.
best stocks to own: Seres Therapeutics, Inc.(MCRB)
Advisors’ Opinion:
- [By Lisa Levin]
Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.
- [By Lisa Levin]
Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
